Pharmaceutical companies are rapidly adopting machine learning platforms to identify suitable candidates for late-stage clinical trials. However, regulatory bodies are stepping in to ensure trial sample diversity and algorithmic transparency.
Validation Standards
Proposed regulatory frameworks require developers to submit training data lineages to prevent demographic bias in trial selection. Early data suggests automated screening reduces recruitment timelines by 30%, provided audit trails satisfy stringent compliance checks.